Editor’s Note November 29, 2011

OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies […]

Read more »

EpiCept’s Ceplene Product Receives Marketing Auth. by European Commission

Ceplene is administered for maintenance of first remission in patients with AML, the most common type of Leukemia in adults.

Read more »

S.E.A. Medical Improves IV Drug Delivery

S.E.A. Medical Systems, Inc. is developing solutions for making intravenous (IV) drug delivery safer for patients.

Read more »

GlySure Develops a Continuous Glucose Monitoring System

GlySure has developed an intravascular sensor capable of continuously monitoring a patient’s glucose for the length of their stay in the ICU.

Read more »

Editor’s Note November 22, 2011

OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies […]

Read more »

DATATRAK’s Product Suite Expands Into Chinese Market Through Tigermed Partnership

DATATRAK International, Inc. announced translation of DATATRAK ONE to Simplified Chinese

Read more »

Dec 13-14, 2011 Oppenheimer Annual Healthcare Conference

The Oppenheimer 22nd Annual Healthcare Conference will take place at the Waldorf=Astoria in New York City, December 13-14, 2011. This […]

Read more »

This Week In Diagnostics

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Read more »

Neovasc’s Refractory Angina Treatment Receives CE Mark

Results of a published prospective three-year clinical study have demonstrated that the Reducer is safe and effective at providing relief of angina symptoms in refractory angina patients.

Read more »

Wound Management Activates Orthopedic Business; Partner Chosen to Develop Products Based on its Patent

Wound Management announced that its subsidiary, Resorbable Orthopedic Products has entered into an agreement with BioStructures.

Read more »